Skip to main content
. 2021 Aug 19;11:732001. doi: 10.3389/fcimb.2021.732001

Table 3.

Distribution of antimicrobial susceptibility of Vibrio species recovered in all sampling sites.

Antimicrobial class Antibiotics V. mimicus (n = 40) V. vulnificus (n = 37) V. fluvialis (n = 41)
S I R S I R S I R
Penicillin Ampicillin (10 µg) 1 (2.5) 1 (2.5) 38 (95.0) 0 (0) 0 (0) 37 (100) 1 (2.4) 4 (9.8) 36 (87.8)
β-lactam combination agent Ampicillin-Sulbactam) (10/10 µg) 5 (12.5) 6 (15.0) 29 (72.5) 1 (2.7) 0 (0) 36 (97.3) 4 (9.8) 0 (0) 37 (90.2)
Carbapenems Imipenem (10 µg) 21 (52.5) 17 (42.5) 2 (5.0) 1 (2.7) 10 (27.0) 26 (70.3) 17 (41.5) 13 (31.7) 11 (26.8)
Meropenem (10 µg) 25 (62.5) 8 (20.0) 7 (17.5) 13 (35.1) 7 (18.9) 17 (45.9) 27 (65.9) 6 (14.6) 8 (19.5)
Aminoglycosides Kanamycin (30 µg) 6 (15) 10 (25.0) 24 (60.0) 9 (24.3) 3 (8.1) 25 (67.8) 10 (24.4) 10 (24.4) 21 (51.2)
Fluoroquinolones Ciprofloxacin (5 µg) 17 (42.5) 19 (47.5) 4 (10.0) 9 (24.3) 24 (64.9) 4 (10.8) 12 (29.3) 18 (43.9) 11 (26.8)
Ofloxacin (5 µg) 10 (25.0) 6 (15.0) 24 (60.0) 4 (10.8) 11 (29.7) 22 (59.5) 12 (29.3) 2 (4.9) 27 (65.9)
Cephalosporins Cefuroxime (30 µg) 6 (15.0) 1 (2.5) 33 (82.5) 0 (0) 2 (5.4) 35 (94.6) 1 (2.4) 2 (4.9) 28 (68.3)
Lipopeptide Polymyxin B (300 µg) 0 (0) 0 (0) 40 (100) 0 (0) 0 (0) 37 (100) 0 (0) 0 (0) 41 (100)
Macrolide Azithromycin (15 µg) 0 (0) 0 (0) 40 (100) 0 (0) 0 (0) 37 (100) 0 (0) 0 (0) 41 (100)
Nitrofurans Nitrofurantoin (300 µg) 1 (2.5) 0 (0) 39 (97.5) 0 (0) 0 (0) 37 (100) 0 (0) 0 (0) 41 (100)
Phenicols Chloramphenicol (30 µg) 0 (0) 0 (0) 40 (100) 0 (0) 0 (0) 37 (100) 0 (0) 3 (7.3) 38 (92.7)

AMP, Ampicillin; SAM, Ampicillin-sulbactam; IPM, Imipenem; MEM, Meropenem; KAN, Kanamycin; CIP, Ciprofloxacin; OFX, Ofloxacin; CXM, Cefuroxime; PB, Polymyxin B; AZM, Azithromycin; NIT, Nitrofurantoin; CHL, Chloramphenicol.